Goldman Raises Potash Price Forecast

Source: NASDAQ (6/28/11)

"Goldman Sachs raises potash price forecast by 6%–9% through 2012."

NASDAQ

We need to see whether today's strength in wheat prices can hold, but one thing we know is that the fertilizers are getting tons of good press. The brokerage firms are loving the Belorussian potash deal with India, and now there are expectations that Brazil will make a deal, as well—at a price 15% to 20% above current spot. Goldman Sachs has raised its forecast on potash prices through 2012 by 6% to 9%, and this actually looks a little low. And Uralkali, the Russian giant, has seen Goldman and two local brokerage firms write gushing notes over the last three days. This company sees potash at $600 a ton by the end of the year, which is extremely aggressive, but it tells you where the fertilizer players feel their market is. While there is no separate wheat ETF that trades in the United States, JJG is 15% weighted to that particular grain:

JJG

With food inflation down, the counterintuitive—or "contrarian"—view is that India, China and Brazil ramp-up their inventories of grain and fertilizer at these new higher prices because the short-term pressure is dropping on them.

Life Sciences Co. Receives Large Livestock Feed Order from New Client in Mexico
Source: Streetwise Reports (01/27/2021)

Avivagen Inc. reported it has secured a six tonne order for OxC-beta™ Livestock from a new customer in Queretaro City, Mexico.

Intrepid Shares Grow 40% on Positive Upward Trend for 2021 Trio and Potash Prices
Source: Streetwise Reports (12/31/2020)

Shares of Intrepid Potash Inc. sprouted to a new 52-week high after the company reported that it anticipates greater demand and higher prices for its Trio® and potash products in 2021.

Life Sciences Firm Reports Year of Record Breaking Orders
Source: Streetwise Reports (12/18/2020)

Avivagen Inc. reported FY/20 audited financial results that included a 20.5% increase in YoY revenue.

Surging Agricultural Prices, $17 Trillion and Phosphate
Source: Brian Ostroff for Streetwise Reports (11/23/2020)

Brian Ostroff, managing director at Windermere Capital and CEO of Arianne Phosphate, discusses the recent rise in agricultural commodity prices and their spillover into fertilizers.

Note to Fed: Be Careful What You Wish For
Source: Michael Ballanger for Streetwise Reports (11/23/2020)

Sector expert Michael Ballanger examines the charts for commodities like soybeans and the components used in handheld electronic devices, and reflects on what they say about the future prospects of those who hold mortgages and invest in precious metals.

Large Scale Automation Comes to Cannabis
Source: Keith Schaefer for Streetwise Reports (11/02/2020)

Keith Schaefer, the Investing Whisperer, offers his analysis of the investment proposition offered by Icanic Brands, and how its ability to generate up to 1,000 pre-rolls per hour could dramatically affect the company's bottom line.

Life Sciences Firm Lands Record 4 Metric Tons Order for Antibiotic-Free Feedstock
Source: Streetwise Reports (10/14/2020)

Avivagen Inc. reported that it has received a record purchase order for its OxC-beta™ product from UNAHCO.

Life Sciences Company Posts Record Q3 Revenue Due to Successful Recurring Purchase Model
Source: Streetwise Reports (09/09/2020)

Avivagen Inc. reported unaudited financial results for Q3/20 that included record revenue and product sales volumes that nearly eclipsed FY/19 levels.

Life Sciences Company Registers First Non-Antibiotic Livestock Feed Additive Sale in Brazil
Source: Streetwise Reports (08/12/2020)

Avivagen Inc. reported it achieved its first sale of OxC-beta™ Livestock in Brazil, the world's third largest livestock feed market.

August Approaches: Accumulation, Conversation and the Promise of Silver
Source: Michael Ballanger for Streetwise Reports (07/20/2020)

In this week's advisory, sector expert Michael Ballanger reviews the most recent market news, celebrates old-school communication techniques and offers strategies for investing in the dog days of summer.